Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
NCT03473223
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18226
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Coronary Syndrome
Interventions
BIOLOGICAL:
Apolipoprotein A-I [human] (apoA-I)
OTHER:
Placebo
Sponsor
CSL Behring